Harlan Krumholz interviews Peter Berger, an editorialist for the HEAT-PPCI study, about the paper’s findings.
Harlan Krumholz discusses a JAMA study that found a substantial proportion of Class I guideline recommendations were not durable over a 10-year period.
This week’s topics are leucocyte telomere length and the risk for CVD, and the association between alcohol and CVD.
Rick Lange and David Hillis wonder whether the debate about the role of FFR and IVUS in patient selection for PCI is a red herring in the larger issue of revascularization in patients with stable CAD.
Colleen K. McIlvennan, Larry A. Allen, and Daniel D. Matlock discuss their study of how patients choose whether to get a left ventricular assist device as destination therapy.
On call is the worst thing about being a doctor, and here’s why.
The following open letter was originally published on The British Medical Journal‘s editorial page regarding the adverse effects of statins for patients with low risk of cardiovascular disease. It was written in response to an analysis by Abramson et al, and more information on the subject can be found here. I have two observations to…
This week’s topics include the effect of patients’ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes, a meta-analysis of revascularization vs. medical treatment in patients with stable CAD, and more.
This week’s topics include atrial fibrillation and cryptogenic stroke, higher potency statins and the risk for new diabetes, and more.
Ethan Weiss discusses how unnecessary cardiovascular screening can lead to serious consequences.